Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02205307 · ClinicalTrials.gov registry record · NA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A NA study, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- Terminated
- Registry status
- NA
- Development phase
- 347
- Enrollment target
NCT02205307: Clinical Trial NA study, sponsored by Novadaq Technologies ULC, now a part of Stryker.
NCT02205307 is a NA study that was terminated before completion, run by Novadaq Technologies ULC, now a part of Stryker. The registered enrollment target is 347 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02205307, a NA study, was terminated before completion, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- TERMINATED
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
Study Summary
This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low anterior resection procedures where colon and rectal tissue perfusion is evaluated using PINPOINT as an adjunct to standard surgical practice compared to surgical procedures performed according to standard surgical practice alone.
Primary Outcome
Anastomotic leak rate in low anterior resection procedures where colon and rectal tissue perfusion is evaluated using PINPOINT Endoscopic Fluorescence imaging or SPY Elite imaging as an adjunct to standard surgical practice compared to surgical procedures performed according to standard surgical practice alone.
Interventions
- DEVICE PINPOINT
- DEVICE SPY Elite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-05 |
| Phase | NA |
Why NCT02205307 stopped before completion
NCT02205307 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which PINPOINT is the first listed.
NCT02205307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02205307 about?
NCT02205307 is a clinical study titled "A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection". This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low anterior resection procedures where colon and rectal tissue perfusion is evaluated using PINPOINT as an adjunct to standard surgical practice compared to surgical ...
What is the current status of trial NCT02205307?
This trial is currently terminated. It is a NA study. The enrollment target is 347 participants. The study started on 2015-01. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02205307?
The interventions under investigation include: PINPOINT (DEVICE), SPY Elite (DEVICE).
Who is sponsoring clinical trial NCT02205307?
This trial is sponsored by Novadaq Technologies ULC, now a part of Stryker, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02205307's enrollment target sits among peer trials
347 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia